https://repositorio.ufba.br/handle/ri/5470
Campo DC | Valor | Idioma |
---|---|---|
dc.contributor.author | Schwingel, Paulo Adriano | - |
dc.contributor.author | Cotrim, Helma Pinchemel | - |
dc.contributor.author | Salles, Bernardo R. | - |
dc.contributor.author | Almeida, Carlos Eduardo Romeu de | - |
dc.contributor.author | Santos Junior, Crimerio Ribeiro dos | - |
dc.contributor.author | Nachef, Bruno | - |
dc.contributor.author | Andrade, Antônio Ricardo de | - |
dc.contributor.author | Zoppi, Cláudio Cesar | - |
dc.creator | Schwingel, Paulo Adriano | - |
dc.creator | Cotrim, Helma Pinchemel | - |
dc.creator | Salles, Bernardo R. | - |
dc.creator | Almeida, Carlos Eduardo Romeu de | - |
dc.creator | Santos Junior, Crimerio Ribeiro dos | - |
dc.creator | Nachef, Bruno | - |
dc.creator | Andrade, Antônio Ricardo de | - |
dc.creator | Zoppi, Cláudio Cesar | - |
dc.date.accessioned | 2012-02-29T18:00:35Z | - |
dc.date.issued | 2011 | - |
dc.identifier.issn | 1478-3231 | - |
dc.identifier.uri | http://www.repositorio.ufba.br/ri/handle/ri/5470 | - |
dc.description | texto completo: acesso restrito. p. 348-353. | pt_BR |
dc.description.abstract | Background: Industrial toxin and drugs have been associated with non-alcoholic fatty liver disease (NAFLD); in these cases, the disease has been termed toxicant-associated steatohepatitis (TASH). Aim: This study hypothe-sizes that the use of anabolic-androgenic steroids (AAS) could also be a risk factor to TASH or better toxicant-associated fatty liver disease (TAFLD) development. Methodology: Case–control study including 180 non-competi-tive recreational male bodybuilders from August/2007 to March/2009. Ninety-five had a history of intramuscular AAS use (cases; G1) and 85 were non-users (controls; G2). They underwent a clinical evaluation and abdominal ultra- sound, and their blood levels of aminotransferases, creatine phosphokinase (CPK), lipids, glucose and insulin were measured. TAFLD criteria: history of AAS use 42 years; presence of hepatic steatosis on ultrasound and/or aminotransferase alterations with normal CPK levels; exclusion of ethanol intake Z20 g/day or use of other drugs; and exclusion of obesity, dyslipidae-mia, diabetes and other liver diseases. Homeostasis model assessment for insulin resistance Z3 was considered insulin resistant. Independent t-test, odds ratio (OR) and 95% confidence intervals (95% CI) were calculated. Results: All cases were asymptomatic. Clinical and laboratorial data were similar in G1 and G2 (P40.05). TAFLD criteria were observed in 12.6% of the G1 cases and 2.4% of controls had criteria compliant with non-alcoholic fatty liver related to metabolic conditions. OR was 6.0 (95% CI: 1.3–27.6). Conclusions: These results suggest that AAS could be a possible new risk factor for TAFLD. In this type of fatty liver disease, the individuals had a low body fat mass and they did not present insulin resistance. | pt_BR |
dc.language.iso | en | pt_BR |
dc.subject | anabolic agents | pt_BR |
dc.subject | drug use | pt_BR |
dc.subject | non-alcoholic | pt_BR |
dc.subject | fatty liver disease | pt_BR |
dc.subject | steatosis | pt_BR |
dc.subject | toxicant | pt_BR |
dc.subject | associated fatty liver disease | pt_BR |
dc.title | Anabolic-androgenic steroids: a possible newrisk factor of toxicant-associated fatty liver disease | pt_BR |
dc.title.alternative | Liver International | pt_BR |
dc.type | Artigo de Periódico | pt_BR |
dc.identifier.number | v. 31. | pt_BR |
dc.embargo.liftdate | 10000-01-01 | - |
Aparece nas coleções: | Artigo Publicado em Periódico (Faculdade de Medicina) |
Arquivo | Descrição | Tamanho | Formato | |
---|---|---|---|---|
Anabolic-androgenic steroids_ a possible newrisk factor of.pdf Restricted Access | 238,94 kB | Adobe PDF | Visualizar/Abrir Solicitar uma cópia |
Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.